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The V y5Nl>1 + -T-cell receptor (TCR)- bearing T-cell 
clone, 2CBET-3, was generated from C57BLl6 mice. 
Upon stimulation, 2CBET-3 cells produce interleukin 
(IL)...;3, granulocyte-m.acrophage colony-stimulating 
factor, and tumor necrosis factor-a, but not ll..-2, ll..-4, 
ll..-S, ll..-6, ll..-8, ll..-10, macrophage colony-stimulating 
factor, or interferon-yo These cells were evaluated for 
their ability to be stimulated by a variety of murine cell 
lines, including fibrobia:sts, trophoblasts, melanoma 
cells, embryonic carcinomas, B-cell lymphomas, mas­
tocytoma cells, and keratinocytes. The human B-Iym­
phoma cell line, Daudi, also was included in these 
studies. We found that 2CBET -3 cells produced cyto­
kines up to several hundredfold above the control levels 
in response to the B-cell lines, Daudi, and A20/2J, but 
not to the B-cellline 439.4.2. After fixation with glu­
taraldehyde, Daudi and A20/2J continued to stimulate 
this Yl> T -cell line. 2CBET -3 cells also responded to the 
keratinocyte line PAM212, but not to another, XB-2. 
M
OSt murine epidermal T cells, having a dendritic 
morphology in vivo, express a uniform T-cell 
receptor (TCR) composed of a V'Y5 and a V81 
gene product [1]. A minor population of epider­
mal T cells expresses V'Y1/V86.3 TCRs and 
responds to the heat shock protein HSP-60 [2]. However, V'Y5/ 
V8l-TCR + epidermal T cells do not resPQnd to HSP-60, and the 
ligands that they recognize have remained elusive. Investigations 
thus far have shown that V'Y5/V81-TCR + epidermal T cells 
respond to fresh keratinocytes and to the keratinocyte cell line 
PAM2l2 [3], as well as to heat-shocked keratinocytes,tt but not to 
spleen cells and fibroblasts [3]. These data suggested that V'YS/V8l­
TCR + epidermal T-cell responsiveness is restricted to keratino­
cytes. However, an observed response of epidermal T-cell clones to 
the B-celllymphoma cell line A2012] (R. E. Tigelaar, unpublished 
data) led us to investigate whether epidermal T cells Can respond to 
other cell types. 
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When lipopolysaccharides (LPS) from Escherichi4 coli or 
S. typhimHriHm were added to 2CBET-3 cells in the 
presence of A20/1J cells, 2CBET -3 cells responded with 
increased cytokine production compared with the cy­
tokine production in the presence of A20/2J cells alone. 
2CBET -3 cells by themselves did not respond to LPS 
alone or to supernatants from A20/2] cells incubated 
with LPS. Ulilike 2CBET-3, the epidermal T-cell hy­
bridoma 70BET-49, expressing a Vy5Nl>1-TCR identi­
cal to that of 2CBET-3, did not respond to A20/2J cells 
in the presence or absence ofLPS, suggesting a require­
ment for molecules other than the TCR for Vy5/Vl>1-
TCR + T-cell stimulation by the B-celllines and by LPS. 
This unique reactivity of Yl>-TCR + cells is different 
from that of afJ-TCR + cells and may re:ft.ect a func­
tional specialization of yl>-TCR + cells in the response 
to bacterial infections. Key words: T lymphocytelB lympho­
cyte. J Invest Devmatol 105:588- 61S, 19!J5 
Because V'Y5/V8l-TCR + epidermal T cells are restricted to the 
epidermis and are therefore likely to serve as a first line of defense, 
they may respond to pathogens or to the products of pathogens, 
such as lipopolysaccharides (LPS), a constituent of gram-negative 
bacteria. Litde information exists as to the LPS responsiveness ofT 
cells. A characteristic that distinguishes B cells from T cells is that 
at least 30% ofB cells are stimulated by LPS, independent ofT-cell 
help, whereas T cells as a rule do not respond to LPS (reviewed in 
[4]). However, a few studies have emerged suggesting that an 
LPS-reactive population of T cells exists. A clonal T -cell line, CT 
6, proliferates in response to LPS without requiring the presence of 
other cells [5]. These investigators also found that a small popula­
tion (approximately 3%) of murine splenic T cells proliferates in 
response to LPS. Similarly, gram-negative bacteria-reactive T cells 
appear to respond to the LPS portion of the bacteria [6]. None of 
these studies addressed whether the LPS-reactive T cells express 
aJ3-TCRs or 'Y8-TCRs. We show herein that V'Y5/V8l-TCR+ 
epidermal T cells respond to LPS in the presence of A2012] cells. 
MATERIALS AND METHODS 
Monoclonal Antibodies The following antibodies were used: 403A.10 
(anti-pan 'YB-TCR) [7], 1701 (anti-V')'5/V81),tt 536 (anti-V'Y5) [8], and 
145-2Cll (anti-CD3) [9]. 
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Figure 1. Cytokine profile of the Vy5NB1-TCR+ epidennal T-cell 
clonal line 2CBET-3. Cytokines were measured by cytokine-specific 
enzyme-linked immunosorbent assays, in which concentrations were deter­
mined in ng/ml. 'Y-1FN, interferon-'Y; TNF-a, tumor necrosis factor-a. 
T-Cell Clonal Line Production and Analysis Epidermal cells were 
prepared from C57BL/6 mice (The Jackson Laboratory, Bar Harbor, ME), 
as described previously [10]. Briefly, whole trunk or ear skin was trypsinized 
ovemight at 4°C. Epidermal cells were gendy separated from the dermis and 
trypsinized at 37°C to produce single-cell suspensions. After nylon wool 
passage to remove non-T cells, the cells were cultured in 24-well plates, 
coated with pan-anti-'Yil TCR [7] together with 10 U/rul recombinant IL-2 
(R and D Systems , Minneapolis, MN), for 72 h. Clonal T-cell lines were 
produced by limiting dilution. The epidermal T-cell clonal lines were 
stained with the above monoclonal antibodies, followed by single-color 
cytofluorometric analysis to confirm that they expressed the V'Y5/Vlll­
TCR. 
Stimulator Cell Lines 2CBET -3 cells were incubated with a variety of 
murine cell lines, including fibroblast cell lines NIH3T3 and L929, tropho­
blast cell line TR-B, melanoma cell line B16FO, embryonic carcinomas 
PCC3 and PCC4, B-celllymphomas 439.4.2 and A20/2J, keratinocyte cell 
Jines XB-2 and PAM212, mastocytoma line P81S, and the human B­
lymphoma cell line Daudi. 
Cell Fixation Stimulator cells (5 X 10· total), suspended in balanced salt 
solution, were fixed with glutaraldehyde (0.05% v/v) for 30 seconds and 
mixed 1:1 with 0.2 M lysine, pH 7.4, in balanced salt solution to stop the 
reaction. Cells were washed further with balanced salt solution before 
incubation with responder T cells. 
Analysis ofEpidennal T-Cell Cytokine Production Cytokines were 
identified by specific enzyme-linked immunosorbent assay techniques at the 
DNAX Research Institute, as described previously [11]. 
Assessment ofEpidennal T-Cell Reactivity Responses to the various 
cell lines or to LPS were detected by cytokine production by 2CBET-3. 
Because 2CBET -3 makes interleukin-3 (IL-3) and granulocyte-macrophage 
colony-stimulating factor (GM-CSF) (Fig 1), culture supernatants from 
experiments involving 2CBET-3 were tested on the IL-3/GM-CSF-depen­
dent DA-l cell line, as described previously [12]. One unit of these 
cytokines was defined as equivalent to 0.001 U of recombinant GM-CSF 
(Genzyme). Recombinant GM-CSF was used as a standard in all assays . 
Units of IL-2 in the culture supernatants of experiments involving the 
epidermal T-cell hybridoma 70BET-49 [2] were measured using the 
cytokine-dependent HT-2 cell line, as described previously [12]. 
LPS LPS from Escherichia coli serotype 055:B5 and S. typhimllrium SL1181 
Re mutant (Sigma Chemical Co., St. Louis, MO) were added to A2012J 
cells and to 2CBET -3 at the start of the culture. 
RESULTS AND DISCUSSION 
The VyS/V81-TCR + epidennal T-cell clone 2CBET-3 was tested 
to detennine which cytokines are produced after activation of these 
T cells. When stimulated by TCR cross-linking. 2CBET -3 pro­
duced IL-3. GM-CSF. and tumor necrosis factor-a: (Fig 1). No 
detectable production of IL-2, IL-4, IL-S, IL-6. IL-8. IL-I0. or 
interferon-y was found. Therefore. we used an IL-3- and GM­
CSF-dependent cell line. DA-l, to assess stimulation of 2CBET-3 
in further experiments. 
2CBET -3 was then tested for responses to a variety of cell lines. 
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Figure 2. Murine and human B-cell lines stimulate 2CBET-3. 
2CBET -3 cells (3 X 105/well) were mixed with Daudi or A2012J cells (1 X 
lOS/well) in microtiter wells. The culture medium was removed and 
assessed for the production ofIL-3 and GM-CSF using the DA-1 bioassay, 
as described in Materials and Methods. The data represent One of five replicate 
experiments. 
as described below. Of all the cells tested, 2CBET-3 responded 
strongly to only two cell lines: the murine B-cell lymphoma cell 
line A2012] and the human B-cell lymphoma Daudi (Fig 2). A 
diiferent VyS/V81-TCR + epidennal T-cell clone, 2CBET-l. re­
sponded similarly to A2012] and Daudi cells (data not shown). 
Fixation of A20/2] and Daudi cells did not interfere with their 
ability to stimulate 2CBET-3 (Fig 3). Thus. the epidennal T-cell 
response was not due to cytokines made by the stimulator cells. 
2CBET -3 cells were not or were only weakly stimulated by other 
cell lines. including the murine B-ce11line 439.2.4, the fibroblast 
cell lines 3T3 and L929. the trophoblast cell line TR-B , the 
melanoma cell line B16FO. embryonic carcinomas PCC3 and 
PCC4. and the mastocytoma line P81S (Fig 4). 
2CBET-3 also responded, albeit to a lesser degree, to the murine 
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Figure 3. 2CBET-3 responds to fixed B-cell lines. 2CBET-3 cells (3 X 
lOs/well) were mixed with A2012J (closed squares) and Daudi (open squares) 
cells that were fixed with glutaraldehyde, as described in Materials and 
Methods. The culture medium was removed and assessed for the production 
of IL-3 and GM-CSF using the DA-1 bioassay. Greater concentrations of 
the fixed B-cell lines were required for maximal responses to occur, 
compared with assays using live cells. The data represent one of three 
replicate experiments. 
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Figure 4. Various cell lines do not stimulate 2CBET-3. 2CBET-3 
cells (3 X 105/well) were mixed with a variety of murine cell lines (1 X 
105/well) in microtiter wells, including fibroblast cell lines NIH3T3 and 
L929, trophoblast cell line TR-B, melanoma cell line B16FO, embryonic 
carcinomas PCC3 and PCC4, B-cell lymphoma 439.4.2, mastocytoma line 
PSIS, and the keratinocyte cell lines XB-2 and PAM212. The culture 
medium was removed from these mixtures and assessed for the production 
of IL-3 and GM-CSF using the DA-l bioassay. Open bars, cytokine 
production by the cell lines alone; closed bars, cytokine production by 
2CBET -3 cells mixed with the cell lines. The data represent one of three 
replicate experiments. 
keratinocyte line PAM212, but showed little reactivity with the 
murine keratinocyte line XB-2 (Fig 4). The reactivity to PAM212 
is consistent with the data of Havran et al [3], in which the 
epidermal T-cell line 7-17 was found to respond strongly to 
PAM212. Dllferences appeared to exist between various V1S/V61-
TCR + epidermal T-cell clones in their reactivity to A20/2J and 
PAM212 cells, with some clones responding preferentially to the 
B-cell lines and others to keratinocytes (R. E. Tigelaar, unpublished 
data). However, 2CBET-3 responses to A2012j cells varied con­
siderably in strength, as can be seen by comparing the responses 
shown in Fig 2 and Fig 5. The reason for the variability of 
responses to A2012j is not clear, but could be related to cell 
densities at which the 2CBET-3 (data not shown) and other 
V1S/V61-TCR + epidermal T-cell clones (R. E. Tigelaar, unpub­
lished data) were maintained before their incubation with A2012j 
cells, such that cell cultures maintained at higher densities displayed 
better responses. Because all of these responding cells expressed the 
same TCR and similar levels of TCR expression (data not shown), 
the variable reactivity may reflect dllferences in expression of 
accessory or adhesion molecules or alternative ligands on the 
V1S/V61-TCR + epidermal T-cell clones. In contrast to the re­
sponses to A2012j cells, the responses of2CBET-3 to PAM212 cells 
have been consistently small. 
Because murine V"S/V61-TCR + epidermal T cells respond to 
both a mouse and a human B-cell line, they may recognize a highly 
conserved ligand. Similarly, V11 -TCR + cells respond to both 
murine and human trophoblast cells and also may recognize a 
highly conserved ligand [13]. The ligand recognized by V1S/V61-. 
TCR + epidermal T cells may not be unique to a particular type of 
cell, as the same epidermal T cells respond to keratinocytes. This 
view contrasts with that of Havran et al [3], who proposed that 
V1S/V81-TCR + epidermal T cells recognize a ligand specific to 
keratinocytes. Alternatively, epidermal T cells may recognize not a 
single ligand but rather a set of related ligands expressed on 
dllferent cells. It is interesting that V1S/V61-TCR + epidermal T 
cells do not respond to all keratinocyte and B-cell lines. This 
finding is reminiscent of the polyclonal responses of human V-y9/ 
V62-TCR + T-cell clones, which respond only to certain B-cell 
lines, particularly the Burkitt's lymphoma line Daudi (14]. Such a 
variable capability of B-cell lines to stimulate 16 T cells could 
reBect variable ligand expression or the expression of accessory 
2000 
1500 
1000 
� � 500 
c: 
2-
en 0 W 
Z 
52 1500 
� 
U 1000 
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
2C8ET-3 
a) b) 
E. coli LPS 
• • • • 
e) f) 
S. typhlmurium 
LPS 
o 1 3 9 o 1 3 9 
g) 
0 ·1 3 9 
708ET-49 
d) 
.Ai A ..eo A 
...... 
h) 
o 3 9 
LIPOPOLYSACCHARIDE CONCENTRATION (1l9/ ml) 
Figure 5. 2CBET-3 is stimulated by bacterial LPS in the presence 
of A20/2] cells. Various concentrations ofLPS from either E. coli (a,b,e,d) 
or S. typhimurium (eJ,g,IJ) were added at the start of the culture to 2CBET-3 
cells (3 X 105/well) mixed withA2012] cells (1 X 105/well), as before. The 
data reflect LPS responses of2CBET-3 alone (a,e; open squares) and A20/2J 
cells alone (a,e; open circles), of 2CBET -3 cells incubated with culture 
supernatants from A2012] cells that had been incubated with LPS for 24 h 
(bJ; closed circles), of2CBET -3 together with A20/2] cells (e,g; closed squares), 
and of the V-yS/VIlI-TCR + hybridoma 70BET-49 (d,h) together with 
(closed triangles) and without (open triangles) A2012] cells. The culture 
medium was removed from these mixtures and assessed for the production 
ofIL-3 and GM-CSF using the DA-l bioassay. Cytokine values shown near 
100 U/ml reflect less than 30 U/ml. These data represent one of three 
replicate experiments. 
molecules such as the integrins or the co stimulatory B7 molecules 
by the B-cell lines (reviewed in [1S,16]). 
Because of the likely exposure of epidermal T cells to pathogens 
from the external environment, 2CBET -3 was assessed for its 
ability to respond to bacterial LPS. 2CBET -3 cells responded to LPS 
in the presence of A20/2j cells, but not in their absence (Fig 5). 
They responded similarly to LPS from two dllferent bacterial 
species, E. coli and s. typhimurium. By themselves, the A2012j cells 
incubated with LPS did not produce cytokines stimulatory for DA-l 
cells (Fig 5). Because the 2CBET-3 response could be due to 
cytokines produced by LPS-activated A2012j cells, we tested the 
ability of culture supernatants from A20/2j cells incubated with 
LPS for 24 h to stimulate the V1S/V61-TCR + cells in the absence 
of A20/ 2j cells. No response was detected (Fig 5). Moreover, the 
necessity for A2012j cells for the 2CBET-3 response to LPS is 
underscored by the finding thatV1SIVB1-TCR + epidermal T cells 
do not respond to LPS adherent to tissue culture plastic (data not 
shown). We also note that although the 2CBET-3 cells responded 
weakly to keratinocyte lines, evaluation of a response to LPS in the 
presence of these cell lines is clouded by the ability of the 
keratinocyte lines to produce IL-3 in response to LPS (personal 
observation). 
In contrast to the LPS response by the V1S/VB1-TCR + clone 
2CBET-3, the V1S/V61-TCR + hybridoma 70BET-49 did not 
respond to LPS under similar conditions, even up to concentrations 
of 100 ILg/mI (data not shown), or to A20/ 2j cells alone (Fig 5). 
Nevertheless, this cell does produce cytokines in response to TCR 
cross-linking with anti-TCR antibodies, suggesting that 70BET-49 
lacks qualities other than V1S/V61-TCR expression that are 
essential for the responses to LPS and to the B-celllines. However, 
the hybridoma fusion partner, BWS1 47, is known to suppress the 
T-cell surface molecule CDS [17], and therefore it also might 
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suppress other accessory molecules required for V'YS/V61-TCR + 
cell responses. 
The observation that V'YS/V61-TCR + epidermal T cells are able 
to respond to bacterial LPS in the presence of A20/2] cells 
distinguishes V'YS/V61-TCR + epidermal T cells from the majority 
ofT lymphocytes, whic� do not respond to LPS [S]. However, LPS 
responsiveness does not appear to be unique to V'YS/V61-TCR + 
epidermal T cells, as murine 'Y6-TCR + cell lines expressing other 
TCRs also were found to be reactive with LPS in the presence of 
accessory cells (M. Tsuji and F. Zavala, data not shown). Thus, the 
mechanism of LPS stimulation is not likely to involve LPS recog­
nition by the TCR. Nevertheless, the sensitivity of 'Y6-TCR + cells 
to LPS stimulation represents an important difference between 
these cells and at3-TCR + cells, and likely reflects different roles of 
the two T-cell subsets in vivo. Possibly, stimulation of 'Y6-TCR + 
cells by LPS (and perhaps by other bacterial products) could initiate 
a cascade of events that affect the host and the pathogen in a 
scenario comparable to superantigen-induced polyclonal at3-
TCR + cell responses. 
Several possibilities exist for the mechanism of stimulation of 
epidermal T cells by LPS in association with A2012] cells. 2CBET-3 
cells either respond to LPS "presented" in some form by A2012] 
cells or respond to another ligand on A20/2] cells whose stimula­
tory activity (e.g., conformation or levels of expression) is induced 
or modified by LPS. Although the LPS molecule is not polyvalent 
per se, it tends to form complexes in aqueous solution, which could 
nonspecifically "glue" the 2CBET-3 and A20/2] cells together. In 
contrast to nonspecific interactions with LPS, A2012] cells may 
express LPS bound to a receptor, such as CD14, CDII/CD18, or 
the 80-kDa LPS-binding protein, and thus the V'YS/V61-TCR + 
epidermal T cells could recognize receptor-bound LPS via a 
member of the CDII/CD18 LPS receptor family (reviewed in 
[18]). In either case, LPS may serve only to enhance other 
cell-surface interactions that lead to epidermal T-cell activation by 
the A20/2] cells. Therefore, one might expect that other cells 
expressing LPS receptors similar to those on A20/2] cells, e.g., 
macrophages, would be able to function in place of A20/2] cells. 
Alternatively, LPS may act on either the epidermal T cells or the 
A20/2J cells to induce or increase the expression of accessory 
molecules important to the response, such as adhesion molecules. 
Also, considering the suggestions of heat shock proteins as possible 
endogenous ligands for V'YS/V61-TCR + epidermal T cells [1], LPS 
has been shown recently to induce expression of HSP-70 in 
macrophages after LPS administration in vivo [19]. Perhaps LPS 
induces expression of HSP-70 or other heat shock proteins on 
A20/2] cells, to which the 2CBET -3 cells respond. 
The ligand on A20/2] cells that stimulates V'YS/V61-TCR + 
epidermal T cells remains unknown at the present time. However, 
the response to LPS in association with A20/2] cells may offer clues 
as to the nature of interactions not only between 'Y6 T cells and 
bacterial pathogens, but also between 'Y6 T cells and other cells of 
the host. That V'YS/V61-TCR + epidermal T cells are activated by 
some B-cell lines in vitro may reflect the ability of these epidermal 
T cells to interact with B lymphocytes in vivo, and such interactions, 
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which have yet to be described, may be important during various 
infections or other pathologic conditions. 
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